Status:
COMPLETED
Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men
Lead Sponsor:
Xavier University of Louisiana.
Collaborating Sponsors:
Tulane University
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Prostate Cancer
Eligibility:
MALE
40-69 years
Phase:
NA
Brief Summary
This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among Af...
Detailed Description
The 2018 U.S. Preventive Services Task Force (USPSTF) final recommendation states that male patients and their providers engage in a shared-decision making process about the benefits and harms of PSA-...
Eligibility Criteria
Inclusion
- Patient
- Receiving care at the clinical sites
- Identify as African American male
- Ages 40-69 years old
- Patient
Exclusion
- Personal history of prostate cancer at the time of consent
- Cognitive impairment that would interfere with participation in the study
- Unable to complete any aspect of the intervention within the specified time limit
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT03869216
Start Date
August 17 2020
End Date
December 31 2023
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane Medical Center
New Orleans, Louisiana, United States, 70112